Kiniksa Pharmaceuticals announces Phase 2/3 trial for KPL-387, targeting recurrent pericarditis, expected mid-2025. Data available in late 2026. Kiniksa Pharmaceuticals announced that it is set to ...
New Rockstars on MSN
MCU phase 4 & 5 timeline explained!
Hector Navarro clarifies the timeline of Marvel's Phase 4 and Phase 5 as we ring in the New Year! Go to for 10% off your ...
InvestorsHub on MSN
Stoke Therapeutics shares slide after updated Phase 3 timeline
Shares of Stoke Therapeutics (NASDAQ:STOK) fell about 18% after the company outlined revised timelines for its Phase 3 ...
CMMC Phase 1 began Nov. 10, and major defense primary contractors are already demanding compliance from their suppliers.
CEO Dan O’Connell highlighted the completion of enrollment for the ALTITUDE AD Phase 2 trial, with 542 participants enrolled in under 10 months. The study focuses on the clinical efficacy and safety ...
Management indicated the COVID-19 Phase IIb trial will continue follow-up for enrolled participants, with a comprehensive data readout anticipated in 2026 and data from the 400-person sentinel cohort ...
Investing.com -- CG Oncology Inc (NASDAQ:CGON) stock surged 18.1% on Friday after the company announced it expects to deliver topline data from its Phase 3 PIVOT-006 clinical trial nearly a year ahead ...
SYDNEY, June 30, 2025 /PRNewswire/ --Actinogen Medical Limited (ASX: ACW) announces that the 100th participant in its pivotal XanaMIA phase 2b/3 randomized trial of Xanamem® for Alzheimer's disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback